Novozymes (NVZMY)
(Delayed Data from OTC)
$60.35 USD
-0.05 (-0.08%)
Updated May 10, 2024 03:59 PM ET
5-Strong Sell of 5 5
F Value C Growth C Momentum F VGM
Price, Consensus and EPS Surprise
NVZMY 60.35 -0.05(-0.08%)
Will NVZMY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NVZMY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NVZMY
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?
Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year?
NVZMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
MATV or NVZMY: Which Is the Better Value Stock Right Now?
Are Basic Materials Stocks Lagging Novozymes (NVZMY) This Year?
MATV vs. NVZMY: Which Stock Is the Better Value Option?
Other News for NVZMY
Warning: NVZMY is at high risk of cutting its dividend
Warning: NVZMY is at high risk of cutting its dividend
Novozymes A/S (NVZMF) Q1 2024 Trading Statement Earnings Call Transcript
Q1 trading statement
Novonesis AS's Dividend Analysis